EPILAPSE-Injection

(Levetiracetam 100 mg/5 mL Injection USP)

“Rapid Control for Acute Seizure Management”

Product Overview

EPILAPSE Injection is a sterile, prescription-based antiepileptic formulation containing Levetiracetam 100 mg/5 mL, designed for intravenous (I.V.) administration. It provides swift stabilization of neuronal hyperactivity in acute seizure episodes or when oral therapy is not feasible, ensuring continuity of care in critical settings.

Key Ingredient & Its Benefits

• Suppresses Hyperactive Nerve Signals: Modulates synaptic neurotransmission to curb abnormal electrical brain activity.

• Fast-Acting Intervention: Achieves rapid therapeutic plasma levels, crucial for acute seizure control.

• USP-Compliant Quality: Manufactured under strict pharmacopeial standards for safety and efficacy.

How EPILAPSE Injection Works

• Immediate Neuronal Stabilization: Binds to synaptic vesicle protein SV2A, reducing neurotransmitter release and hyperexcitability.

• Rapid Bioavailability: Direct I.V. infusion ensures 100% bioavailability, bypassing gastrointestinal absorption delays.

• Seamless Transition: Often used as an alternative to oral therapy in hospitalized patients or during emergencies.

Indications

• EPILAPSE Injection is indicated for:

  • Acute Management of Seizures (partial, myoclonic, or generalized tonic-clonic) when oral administration is temporarily unavailable.

  • Adjunctive Therapy in hospitalized patients requiring rapid seizure control.

  Consult a neurologist to determine suitability for your condition.

Recommended Usage

• Dosage: Typically 500–1500 mg/day (5–15 mL), divided into 2 doses, adjusted per clinical response and physician guidance.

• Administration:

  • Dilute in 100 mL of compatible diluent (e.g., NaCl 0.9%, dextrose 5%).

  • Infuse over 15–30 minutes to minimize adverse reactions.

• Duration: Transition to oral therapy as soon as clinically appropriate.

Always adhere to prescribed infusion protocols.

Key Benefits

1. Emergency-Ready Action

   • Delivers rapid seizure control within minutes, critical for acute episodes.

2. Hospital & Clinical Flexibility

   • Ideal for patients unable to tolerate oral medications or requiring urgent care.

3. Consistent Therapeutic Levels

   • Maintains steady plasma concentrations for uninterrupted seizure management.

4. Low Interaction Risk

   • Minimal interference with co-administered antiepileptics or emergency medications.

Safety & Precautions

• Monitor for Reactions: Potential side effects include dizziness, somnolence, or injection-site pain. Rarely, psychiatric symptoms (e.g., agitation) may occur.

• Contraindications: Hypersensitivity to Levetiracetam or injection excipients.

• Storage: Store at 20–25°C; protect from light. Use immediately after dilution.

• Do Not Administer Rapidly: Strictly adhere to infusion duration to avoid adverse effects.

Why Choose EPILAPSE-500?

• Critical Care Optimized: Trusted in emergency and inpatient settings for reliable, rapid action.

• USP-Verified Purity: Ensures batch-to-batch consistency and compliance with global standards.

• Smooth Oral Transition: Facilitates continuity of care from hospital to home.

Disclaimer: The information provided here is for educational purposes only and should not replace professional medical advice. Always consult your healthcare provider to determine the best treatment plan for your specific condition.